202 related articles for article (PubMed ID: 28550834)
1. [Bullous Pemphigoid Successfully Treated with Rituximab].
Silva N; Costa A; Salvador F; Serradeiro E
Acta Med Port; 2017 Mar; 30(3):243-246. PubMed ID: 28550834
[TBL] [Abstract][Full Text] [Related]
2. Remission Time after Rituximab Treatment for Autoimmune Bullous Disease: A Proposed Update Definition.
Iranzo P; Pigem R; Giavedoni P; Alsina-Gibert M
Skin Pharmacol Physiol; 2015; 28(5):255-6. PubMed ID: 26021780
[TBL] [Abstract][Full Text] [Related]
3. Refractory childhood pemphigoid successfully treated with rituximab.
Fuertes I; Luelmo J; Leal L; Romaní J; Sánchez S; Mascaró JM
Pediatr Dermatol; 2013; 30(5):e96-7. PubMed ID: 23278674
[TBL] [Abstract][Full Text] [Related]
4. Positive clinical outcome in a patient with recalcitrant bullous pemphigoid treated with rituximab and intravenous immunoglobulin.
Nguyen T; Ahmed AR
Clin Exp Dermatol; 2017 Jul; 42(5):516-519. PubMed ID: 28508388
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
Front Immunol; 2018; 9():248. PubMed ID: 29520266
[TBL] [Abstract][Full Text] [Related]
6. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
[TBL] [Abstract][Full Text] [Related]
7. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
Wallet-Faber N; Franck N; Batteux F; Mateus C; Gilbert D; Carlotti A; Avril MF; Dupin N
Dermatology; 2007; 215(3):252-5. PubMed ID: 17823525
[TBL] [Abstract][Full Text] [Related]
8. First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid.
Cho YT; Chu CY; Wang LF
Br J Dermatol; 2015 Jul; 173(1):302-4. PubMed ID: 25529394
[No Abstract] [Full Text] [Related]
9. Infantile Bullous Pemphigoid Treated Using Intravenous Immunoglobulin: Case Report and Review of the Literature.
Tekin B; Yücelten AD
Pediatr Dermatol; 2015; 32(5):723-6. PubMed ID: 26119800
[TBL] [Abstract][Full Text] [Related]
10. Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid.
Sowerby L; Dewan AK; Granter S; Gandhi L; LeBoeuf NR
JAMA Dermatol; 2017 Jun; 153(6):603-605. PubMed ID: 28355425
[No Abstract] [Full Text] [Related]
11. Pemphigoid nodularis: An infrequent variant responding to rituximab.
Vila-Payeras A; Domínguez-Mahamud C; Terrasa-Sagristà F; Vila-Mas A; Parera-Amer E; Nadal-Lladó C
Australas J Dermatol; 2020 Nov; 61(4):e438-e439. PubMed ID: 32408380
[No Abstract] [Full Text] [Related]
12. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
[TBL] [Abstract][Full Text] [Related]
13. Three cases of refractory bullous pemphigoid in the elderly treated successfully with ultra-low-dose rituximab.
Chen Q; Hu B; Wan L; Hu L; Zhou X; Chen L; Chen J
J Dermatol; 2023 Apr; 50(4):561-564. PubMed ID: 36539929
[TBL] [Abstract][Full Text] [Related]
14. Severe bullous pemphigoid in an infant--successful treatment with rituximab.
Schulze J; Bader P; Henke U; Rose MA; Zielen S
Pediatr Dermatol; 2008; 25(4):462-5. PubMed ID: 18789089
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in refractory autoimmune bullous diseases.
Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
[TBL] [Abstract][Full Text] [Related]
16. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low-dose methotrexate.
Wang TS; Tsai TF
Acta Derm Venereol; 2014 Jan; 94(1):108-9. PubMed ID: 23624752
[No Abstract] [Full Text] [Related]
17. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
Reguiaï Z; Tchen T; Perceau G; Bernard P
Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bullous pemphigoid with rituximab: critical analysis of the current literature.
Shetty S; Ahmed AR
J Drugs Dermatol; 2013 Jun; 12(6):672-7. PubMed ID: 23839185
[TBL] [Abstract][Full Text] [Related]
19. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
[TBL] [Abstract][Full Text] [Related]
20. Refractory bullous pemphigoid with fatal outcome in a young patient.
Cruz MJ; Santos P; Morais P; Barreto F; Azevedo F
Int J Dermatol; 2013 May; 52(5):601-2. PubMed ID: 23590375
[No Abstract] [Full Text] [Related]
[Next] [New Search]
